Vaxart Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Vaxart Inc
VXRT Stock  USD 0.58  0.03  4.90%   
Analyzing historical trends in various income statement and balance sheet accounts from Vaxart's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Vaxart's valuation are summarized below:
Gross Profit
-30.9 M
Profit Margin
(0.34)
Market Capitalization
146.4 M
Enterprise Value Revenue
0.9466
Revenue
148.2 M
There are currently one hundred twenty fundamental trend indicators for Vaxart Inc that can be evaluated and compared over time across competition. All traders should double-check Vaxart's current fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 275.8 M in 2026. Enterprise Value is likely to drop to about 274.2 M in 2026

Vaxart Total Revenue

24.54 Million

Check Vaxart financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxart's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.7 M, Interest Expense of 1.9 M or Total Revenue of 24.5 M, as well as many indicators such as Price To Sales Ratio of 9.61, Dividend Yield of 0.27 or PTB Ratio of 5.98. Vaxart financial statements analysis is a perfect complement when working with Vaxart Valuation or Volatility modules.
  
Build AI portfolio with Vaxart Stock
Check out the analysis of Vaxart Correlation against competitors.

Vaxart Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets151.4 M191.3 M105 M
Slightly volatile
Short and Long Term Debt Total29.7 M21 M13.4 M
Slightly volatile
Other Current Liabilities92.7 M88.3 M20.8 M
Slightly volatile
Total Current Liabilities109.7 M104.5 M27.8 M
Slightly volatile
Total Stockholder Equity88.7 M67.8 M66.9 M
Slightly volatile
Property Plant And Equipment Net27.3 M26.2 M12.1 M
Slightly volatile
Cash51.6 M29 M53.1 M
Very volatile
Non Current Assets Total92.7 M88.3 M31.2 M
Slightly volatile
Cash And Short Term Investments61.1 M59.5 M64.9 M
Pretty Stable
Net Receivables11.5 M10.8 M6 M
Very volatile
Common Stock Shares Outstanding588.4 M560.4 M235.2 M
Slightly volatile
Liabilities And Stockholders Equity151.4 M191.3 M105 M
Slightly volatile
Non Current Liabilities Total27.2 M14.9 M14.4 M
Slightly volatile
Other Current Assets4.9 M4.1 M2.3 M
Slightly volatile
Other Stockholder Equity646.5 M615.7 M274.9 M
Slightly volatile
Total Liabilities101.6 M96.7 M38.8 M
Slightly volatile
Property Plant And Equipment Gross24.9 M35.7 M11.9 M
Slightly volatile
Total Current Assets94.5 M78.5 M74.4 M
Pretty Stable
Short Term Debt6.7 M6.4 M2.5 M
Slightly volatile
Accounts Payable5.7 M6.3 M4 M
Very volatile
Common Stock Total Equity11.1 K11.7 K2.1 M
Slightly volatile
Common Stock19.7 K20.7 K1.9 M
Slightly volatile
Capital Surpluse528.9 M503.7 M281.4 M
Slightly volatile
Property Plant Equipment18.8 M17.9 M5.9 M
Slightly volatile
Non Current Liabilities Other2.3 M2.5 M6 M
Pretty Stable
Deferred Long Term Asset Charges560 K450 K594.7 K
Slightly volatile
Long Term Debt Total2.1 M2.2 M3.5 M
Very volatile
Net Invested Capital80.4 M67.8 M50.7 M
Slightly volatile
Capital Stock19.7 K20.7 K668.6 K
Pretty Stable
Capital Lease Obligations15 M20.2 M8.1 M
Slightly volatile

Vaxart Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization10.7 M10.2 M3.9 M
Slightly volatile
Total Revenue24.5 M25.8 M19.4 M
Slightly volatile
Other Operating Expenses75.5 M85.5 M55.3 M
Slightly volatile
Cost Of Revenue3.8 M4 M15.2 M
Slightly volatile
Total Operating Expenses114.7 M109.2 M46.6 M
Slightly volatile
Selling General Administrative21 M18.7 M13.5 M
Slightly volatile
Research Development89.6 M85.3 M37.6 M
Slightly volatile
Interest Income3.1 M2.9 M821.4 K
Slightly volatile
Reconciled Depreciation5.1 M10.2 M3.3 M
Slightly volatile
Preferred Stock And Other Adjustments271.2 K305.1 K333 K
Slightly volatile
Selling And Marketing Expenses3.6 M4 M4.4 M
Slightly volatile

Vaxart Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation8.4 M8 M3.8 M
Slightly volatile
End Period Cash Flow52.5 M29 M52.3 M
Very volatile
Begin Period Cash Flow50.7 M40 M49 M
Pretty Stable
Stock Based Compensation13.9 M13.2 M5.6 M
Slightly volatile
Issuance Of Capital Stock45.4 M50.7 M35.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.6110.12524
Slightly volatile
Dividend Yield0.270.30.3298
Slightly volatile
Days Sales Outstanding14413794.4559
Slightly volatile
Stock Based Compensation To Revenue0.340.368.3626
Pretty Stable
Capex To Depreciation0.06840.0720.9901
Pretty Stable
EV To Sales9.5510.06504
Slightly volatile
Inventory Turnover6.633.773.5688
Slightly volatile
Days Of Inventory On Hand53.42100106
Pretty Stable
Payables Turnover3.13.277.5272
Slightly volatile
Sales General And Administrative To Revenue0.620.6518.4407
Pretty Stable
Research And Ddevelopement To Revenue2.212.3350.019
Pretty Stable
Capex To Revenue0.01650.01745.6865
Pretty Stable
Cash Per Share0.09080.09552.2623
Slightly volatile
Days Payables Outstanding12111682.7248
Pretty Stable
Intangibles To Total Assets0.0530.05570.1039
Very volatile
Current Ratio0.640.685.3673
Slightly volatile
Receivables Turnover2.622.766.5098
Slightly volatile
Capex Per Share0.00120.00130.1573
Slightly volatile
Revenue Per Share0.06430.06771.4009
Slightly volatile
Interest Debt Per Share0.05890.0620.2779
Slightly volatile
Debt To Assets0.120.130.6064
Very volatile
Graham Number16.8911.1812.1821
Slightly volatile
Operating Cycle87.3313796.0498
Very volatile
Days Of Payables Outstanding12111682.7248
Pretty Stable
Ebt Per Ebit1.351.160.9932
Slightly volatile
Long Term Debt To Capitalization0.03060.03220.0479
Pretty Stable
Total Debt To Capitalization0.240.251.6738
Very volatile
Quick Ratio0.640.685.3489
Slightly volatile
Net Income Per E B T0.620.90.9606
Very volatile
Cash Ratio0.240.253.9607
Slightly volatile
Days Of Inventory Outstanding53.42100106
Pretty Stable
Days Of Sales Outstanding14413794.4559
Slightly volatile
Fixed Asset Turnover0.840.8921.9631
Slightly volatile
Debt Ratio0.120.130.6064
Very volatile
Price Sales Ratio9.6110.12524
Slightly volatile
Asset Turnover0.190.20.2671
Slightly volatile

Vaxart Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap275.8 M290.4 M840.9 M
Pretty Stable
Enterprise Value274.2 M288.6 M806.5 M
Pretty Stable

Vaxart Fundamental Market Drivers

Forward Price Earnings42.735
Cash And Short Term Investments51.7 M

Vaxart Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Vaxart Financial Statements

Vaxart shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Vaxart investors may analyze each financial statement separately, they are all interrelated. The changes in Vaxart's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vaxart's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue75.2 M79 M
Total Revenue25.8 M24.5 M
Cost Of Revenue4 M3.8 M
Stock Based Compensation To Revenue 0.36  0.34 
Sales General And Administrative To Revenue 0.65  0.62 
Research And Ddevelopement To Revenue 2.33  2.21 
Capex To Revenue 0.02  0.02 
Revenue Per Share 0.07  0.06 
Ebit Per Revenue(2.66)(2.79)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY